Pharmaceutical Market Europe • January 2022 • 3
COMMENT
Welcome to 2022!
While the world’s focus has been firmly fixed on the COVID-19 pandemic for the last two years, there is another hidden crisis in Europe: cardiovascular disease. CVD is the continent’s number one killer, accounting for 3.9 million deaths and costing the European Union €210bn. The article on page 18 investigates this growing crisis and looks at the need for a new strategy.
Over the past two years, the restrictions on travel caused by the COVID-19 pandemic have had a huge, knock-on effect on national and international congresses and conferences.
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay. Read more on page 30.
I hope you enjoy this issue!
Langland, a Publicis Health company,
presents a webinar hosted by PMLiVE
Date: 20 January at 2pm
After the wildfire: how will healthcare recover from the pandemic?
After a forest fire, the natural world recovers according to predictable patterns, in a process known as ‘ecological succession’. The modern world has never seen a global conflagration quite like COVID-19, so what will those equivalent patterns look like for healthcare? Join Langland and a panel of health experts as they ask how the pandemic will change the way individuals manage their own health, how healthcare companies interact with patients, and the status of health literacy on the global health agenda.
There is a strong panel of speakers lined up, with representatives from Langland being joined by healthcare experts, so make sure you join us on Thursday 20 January at 2pm for this free webinar session. See https://tinyurl.com/54ndcuvc for more details.
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Journalist/editorial assistant Fleur Jeffries
Studio:
Executive Director
Karl Equi
Senior Designer
Peter May
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2021 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW